Rosefinch Investment

Rosefinch Investment began as a private securities fund manager in 2007 and later transitioned into a public mutual fund license, now operating as Rosefinch Fund. This conversion allows the firm to manage regulated public fund products alongside residual private strategies, a structure that gives it access to both retail and institutional capital within China's domestic market.

Longtime Chairman 梁跃军 (Liang Yuejun) has led the firm since its founding and remains the public face of its investment strategy. He has publicly articulated a philosophy favoring concentrated, conviction-weighted positioning during periods of major market change (per China Securities Journal, 2018). No additional named investment committee members are publicly disclosed.

Rosefinch targets early-stage, growth, and pre-IPO opportunities according to its stated strategy. The firm does not publish a breakdown of committed capital by stage nor name specific portfolio companies, making it difficult to assess vintage concentration or check sizes.

The public mutual fund license provides regulatory standing and a broader institutional investor base, while the private heritage preserves relationships within China's pre-IPO and growth-stage ecosystem. The firm has not detailed how deal flow is shared or firewalled between the two entities, nor whether co-investment rights are extended to public fund investors.

Rosefinch's public commentary is macro-oriented, referencing broad domestic recovery trends rather than sectoral mandates. The August 2025 donation to Tsinghua University's brain-science and AI research suggests a thematic interest, but no exclusion list or explicit sector-avoidance policy has been published.